Evaluates antidiarrheal effects of myricitrin extract in mice, indicating potential therapeutic benefits.
Eugenia uniflora L. has been traditionally used for the treatment of gastrointestinal disorders, including diarrhoea, however, pharmacological studies using chemically standardised preparations remain limited. In this study, a myricitrin-enriched extract from E. uniflora leaves was developed and chemically standardised. Myricitrin was quantified by a validated HPLC–PDA method to ensure batch reproducibility. Antidiarrheal activity was evaluated in a castor oil-induced diarrhoea model in mice, and safety was assessed by cytotoxicity assays (MTT and neutral red uptake) and acute oral toxicity (2000 mg/kg). The extract showed marked flavonoid enrichment and low cytotoxicity, with no mortality observed in vivo (LD50 > 2000 mg/kg). Oral administration significantly reduced diarrheal episodes in a dose-dependent manner, with effects comparable to loperamide at the highest dose. These findings support the pharmacological relevance of a chemically standardised E. uniflora extract.
No takes yet. Share an insight, caveat, or question.
Quadros et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: